Advertisement

AdvanSource Biomaterials Corp., a maker of polymer technologies for medical devices, has said it will not appeal the New York Stock Exchange’s decision to delist the company from its Amex exchange.

Instead, the Wilmington company intends to qualify its common stock for trading on the Over-the-Counter Bulletin Board.

SOURCE

Advertisement
Advertisement